Comparative Effectiveness and Safety of Sodium-Glucose Cotransporter 2 Inhibitors Versus Glucagon-Like Peptide 1 Receptor Agonists in Older Adults. uri icon

authors

  • Patorno, Elisabetta
  • Kim, Seoyoung C
  • Pawar, Ajinkya
  • Bessette, Lily G
  • Dae Hyun Kim, MD, MPH, ScD
  • Dave, Chintan
  • Glynn, Robert J
  • Munshi, Medha N
  • Schneeweiss, Sebastian
  • Wexler, Deborah J

publication date

  • January 1, 2021